6749
clinical study

Initial Experience With an Artificial Intelligence System for Pulmonary Embolism Response Team Activation and Coordination in a Large Urban Health System

Materials & Methods

All CT pulmonary angiograms between Jan. and Aug. 2022, were triaged using an AI-based automated PERT activation algorithm. AI PERT activation was based on the location of clot (central vs. peripheral) and CT evidence of right ventricular strain (RV to LV ratio greater than 1.0). A retrospective review was conducted of all institutional PERT activations over the same period.

Results

Pulmonary embolism was identified on 954 CT pulmonary angiograms, and the AI algorithm sent an automated PERT notification on 155 (16.2%) of these. The institutional PERT was formally activated for 121 patients, of whom 38 underwent at least one intervention beyond anticoagulation alone (three systemic thrombolysis, four surgical thrombectomy, six catheter-directed thrombolysis, 19 percutaneous thrombectomy, 15 inferior vena cava filter, and two ECMO). Thirty-two patients who initially presented to satellite facilities were transferred to a hospital with both endovascular and open cardiothoracic surgery capabilities. The sensitivity and specificity of the AI algorithm for identifying true PERT activations were 62.8% and 90.5% respectively. Among patients requiring transfer for possible intervention, sensitivity was 84.4% and specificity 88.1%. Among patients who underwent any intervention, sensitivity was 78.9% and specificity 86.4%. When catheter-directed intervention is considered separately, sensitivity and specificity were 95.8% and 85.8% respectively.

Conclusions

The system’s initial experience demonstrates high sensitivity and specificity of the AI algorithm in identifying candidates for endovascular pulmonary embolism intervention despite poor correlation with PERT activations overall. Ongoing research will further assess the clinical benefits and optimal uses for this technology.

Explore the Latest AI Insights, Trends and Research

Aidoc Staff

Marlee Ravid

<p>Marlee Ravid brings over a decade of experience in content marketing, communications and customer engagement to her role as Customer Marketing Manager at Aidoc.</p> <p>She strategically executes innovative programs that amplify the leadership of both Aidoc and its customers, helping to position them as visionaries in healthcare. Having been with Aidoc since its early days, Ravid has worked closely with leadership to build and implement comprehensive marketing strategies, from content development to demand generation and brand awareness.</p> <p>She holds a bachelor’s degree from Georgia State University and a master’s degree from Tel Aviv University.</p>

Heather Cmiel

<p>Heather Cmiel is an accomplished marketing and communications leader with a proven track record of driving business results using integrated marketing, brand and communications strategies combined with execution excellence. She currently serves as the Vice President of Brand and Communications at Aidoc.</p> <p>Cmiel previously led marketing communications for the Medical Solutions Division at 3M Health Care, now Solventum. Her extensive experience also includes key roles at Bellmont Partners, Weber Shandwick and Maccabee Group.</p> <p>She holds a master’s degree in communication from Purdue University, and is an adjunct professor at the University of St. Thomas. Cmiel is an accredited member of the Public Relations Society of America (PRSA), and is a past president of the Minnesota PRSA chapter.</p>